GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brooks Laboratories Ltd (BOM:533543) » Definitions » EV-to-FCF

Brooks Laboratories (BOM:533543) EV-to-FCF : (As of Jun. 22, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Brooks Laboratories EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Brooks Laboratories's Enterprise Value is ₹2,394.0 Mil. Brooks Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.0 Mil. Therefore, Brooks Laboratories's EV-to-FCF for today is .

The historical rank and industry rank for Brooks Laboratories's EV-to-FCF or its related term are showing as below:

BOM:533543' s EV-to-FCF Range Over the Past 10 Years
Min: -318.32   Med: 0   Max: 0
Current: -22.26

BOM:533543's EV-to-FCF is ranked worse than
100% of 535 companies
in the Drug Manufacturers industry
Industry Median: 22.83 vs BOM:533543: -22.26

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-22), Brooks Laboratories's stock price is ₹90.00. Brooks Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-5.920. Therefore, Brooks Laboratories's PE Ratio for today is At Loss.


Brooks Laboratories EV-to-FCF Historical Data

The historical data trend for Brooks Laboratories's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brooks Laboratories EV-to-FCF Chart

Brooks Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.43 -159.33 -4.10 -10.77 -24.38

Brooks Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -10.77 - - -24.38

Competitive Comparison of Brooks Laboratories's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Brooks Laboratories's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brooks Laboratories's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Brooks Laboratories's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Brooks Laboratories's EV-to-FCF falls into.



Brooks Laboratories EV-to-FCF Calculation

Brooks Laboratories's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2394.040/0
=

Brooks Laboratories's current Enterprise Value is ₹2,394.0 Mil.
Brooks Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brooks Laboratories  (BOM:533543) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Brooks Laboratories's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=90.00/-5.920
=At Loss

Brooks Laboratories's share price for today is ₹90.00.
Brooks Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-5.920.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Brooks Laboratories EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Brooks Laboratories's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Brooks Laboratories (BOM:533543) Business Description

Traded in Other Exchanges
Address
Off. Andheri Kurla Road, 201, The Summit Business Park, Behind Guru Nanak Petrol Pump, Andheri (East), Mumbai, MH, IND, 400 093
Brooks Laboratories Ltd is an Indian company operating in the healthcare sector. The company is engaged in the formulation, development, production, and export of drugs and pharmaceuticals. It has manufacturing sites located in Baddi, Himachal Pradesh, and Vadodara, Gujarat. It manufactures drugs in a variety of forms, including tablets, dry syrup, injections, liquid injections, dry powder injections, eye drops, and ear drops. Its products include carbapenem and penicillins.

Brooks Laboratories (BOM:533543) Headlines

No Headlines